论文部分内容阅读
核心提示:早在2006年10月11日,党的十六届六中全会就已经明确提出,建立国家基本药物制度,整顿药品生产和流通秩序,保证群众基本用药。2007年1月8日,卫生部部长高强在2007年全国卫生工作会议上宣布,建立国家基本药物制度将成为国家医疗体制改革的四项基本制度之一。2007年1月17日,在全国食品药品监督管理工作会议上,国家食品药品监督管理局局长邵明立指出,建立国家基本药物制度将成为2007年药品监管工作的一项主要任务。一时间,国家基本药物制度如何构建、基本药物制度能否成为解决目前看病贵以及药价虚高的一剂猛药成为社会各界关注的焦点。针对基本药物制度在修订过程中会遇到哪些潜在问题,本刊记者走访了药品监管方面的有关专家。
As early as October 11, 2006, the Sixth Plenary Session of the 16th CPC Central Committee has explicitly proposed establishing a national basic drug system, reorganizing the order of drug production and distribution, and ensuring the masses’ basic medication. On January 8, 2007, Minister of Health Gao Qiang announced at the 2007 National Conference on Health Work that the establishment of a national essential drug system will become one of the four basic systems for the reform of state medical system. On January 17, 2007, at the National Food and Drug Administration Work Conference, Shao Mingli, director of the State Food and Drug Administration, pointed out that the establishment of a national essential drug system will become a major task of pharmaceutical supervision in 2007. For a time, how to construct the national essential drug system, and whether the basic drug system can become a powerful drug to solve the current expensive medical treatment and the high price of drugs, has become the focus of attention from all walks of life. In response to the basic drug system in the revision process will encounter any potential problems, correspondents visited the drug regulatory experts.